IGBA Statement on the Final Report of the United Nations Secretary General’s High Level Panel on Access to Medicines
November 15, 2016 – Geneva, Switzerland – The International Generic and Biosimilar Medicines Association (IGBA) believes that generic and biosimilar medicines can play a fundamental role in improving access to high quality medicines for patients worldwide.
